Novo Nordisk is dismissing its patent infringement lawsuit against telehealth company Hims & Hers, as the two companies have ...

Hims & Hers shares jumped more than 50% in premarket trade on Monday after ending a dispute with Novo Nordisk by striking a partnership with the Danish drug giant.

Hers is currently offering 20% off GLP-1 medication for eligible subscribers who pay over $500 for weight-loss services.

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug ...

After years of fighting over compounded weight loss drugs, Hims & Hers and Novo Nordisk are teaming up to sell Ozempic and Wegovy — a shift that could raise costs for patients.

NOVO B, has settled its legal dispute with Hims & Hers Health over unauthorized versions of Wegovy and Ozempic. The companies ...

Novo Nordisk has dismissed its patent infringement lawsuit against telehealth provider Hims & Hers, following an agreement that will see the pharmaceutical giant’s branded weight loss medications sold ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug following the Food and Drug ...

The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of New York City, New York, U.S., January 21, 2021. REUTERS/Carlo Allegri ...

Hims & Hers HIMS recently announced that it is expanding access to its comprehensive Weight Loss Program to customers in the United Kingdom. The company is launching its Hers platform to provide ...

Add Yahoo as a preferred source to see more of our stories on Google. The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of ...